Conditions for combining gene therapy with bone marrow transplantation in murine Krabbe disease.

Authors

Mohammad Rafi, Department of Neurology, Sidney Kimmel College of Medicine, Thomas Jefferson University, Philadelphia, PA 19107, United StatesFollow
Paola Luzi, Department of Neurology, Sidney Kimmel College of Medicine, Thomas Jefferson University, Philadelphia, PA 19107, United States
David A Wenger, Department of Neurology, Sidney Kimmel College of Medicine, Thomas Jefferson University, Philadelphia, PA 19107, United StatesFollow

Document Type

Article

Publication Date

1-1-2020

Comments

This article has been peer reviewed. It was published in: BioImpacts.

Volume 10, Issue 2, 2020, Pages 105-115.

The published version is available at DOI: 10.34172/bi.2020.13

Copyright © 2020 The Author(s)

This work is published by BioImpacts as an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited.

Recommended Citation

Rafi, Mohammad; Luzi, Paola; and Wenger, David A, "Conditions for combining gene therapy with bone marrow transplantation in murine Krabbe disease." (2020). Department of Neurology Faculty Papers. Paper 218.
https://jdc.jefferson.edu/neurologyfp/218

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License

PubMed ID

32363154